Perla Lansang

913 total citations
37 papers, 525 citations indexed

About

Perla Lansang is a scholar working on Dermatology, Immunology and Allergy and Immunology. According to data from OpenAlex, Perla Lansang has authored 37 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Dermatology, 13 papers in Immunology and Allergy and 12 papers in Immunology. Recurrent topics in Perla Lansang's work include Dermatology and Skin Diseases (23 papers), Psoriasis: Treatment and Pathogenesis (12 papers) and Allergic Rhinitis and Sensitization (11 papers). Perla Lansang is often cited by papers focused on Dermatology and Skin Diseases (23 papers), Psoriasis: Treatment and Pathogenesis (12 papers) and Allergic Rhinitis and Sensitization (11 papers). Perla Lansang collaborates with scholars based in Canada, United States and United Kingdom. Perla Lansang's co-authors include Elena Pope, Jensen Yeung, Neil H. Shear, Nhung Ho, Melinda Gooderham, Kim Papp, Erika Yue Lee, Vimal H. Prajapati, Raed Alhusayen and Irina Turchin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Academy of Dermatology and British Journal of Clinical Pharmacology.

In The Last Decade

Perla Lansang

34 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Perla Lansang Canada 13 297 138 120 114 112 37 525
Igor Snast Israel 11 271 0.9× 158 1.1× 66 0.6× 102 0.9× 47 0.4× 41 555
Caleb Hwang Taiwan 8 95 0.3× 105 0.8× 32 0.3× 148 1.3× 53 0.5× 12 453
Jeffrey Zweegers Netherlands 14 245 0.8× 455 3.3× 17 0.1× 73 0.6× 86 0.8× 19 610
A. Villani France 13 342 1.2× 494 3.6× 27 0.2× 109 1.0× 76 0.7× 52 794
Alexander Marsland United Kingdom 15 238 0.8× 293 2.1× 54 0.5× 242 2.1× 14 0.1× 29 648
S.P. Menting Netherlands 9 192 0.6× 504 3.7× 14 0.1× 50 0.4× 129 1.2× 13 585
María Jones‐Caballero Spain 14 360 1.2× 140 1.0× 23 0.2× 79 0.7× 50 0.4× 27 567
Sujoy Khan United Kingdom 11 37 0.1× 104 0.8× 38 0.3× 50 0.4× 62 0.6× 50 400
Ravishankar Sargur United Kingdom 12 43 0.1× 89 0.6× 62 0.5× 24 0.2× 72 0.6× 26 379
M. Fazio Italy 15 223 0.8× 356 2.6× 30 0.3× 60 0.5× 32 0.3× 34 628

Countries citing papers authored by Perla Lansang

Since Specialization
Citations

This map shows the geographic impact of Perla Lansang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perla Lansang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perla Lansang more than expected).

Fields of papers citing papers by Perla Lansang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perla Lansang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perla Lansang. The network helps show where Perla Lansang may publish in the future.

Co-authorship network of co-authors of Perla Lansang

This figure shows the co-authorship network connecting the top 25 collaborators of Perla Lansang. A scholar is included among the top collaborators of Perla Lansang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perla Lansang. Perla Lansang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lovegrove, Fiona, Maxwell Sauder, Asfandyar Mufti, et al.. (2025). Navigating Bullous Pemphigoid: Consensus Recommendations for Diagnosis and Management—A Canadian Perspective. Journal of Cutaneous Medicine and Surgery. 29(6). 661–674.
2.
Papp, Kim, Ronald Vender, Fiona Lovegrove, et al.. (2025). Time to Onset of Action for Biologics and Targeted Treatments in Psoriasis: Systematic Targeted Literature Review and Network Meta-Analysis. Dermatology and Therapy. 15(9). 2615–2629.
3.
Prajapati, Vimal H., Charles Lynde, Melinda Gooderham, et al.. (2024). Considerations for defining and diagnosing generalized pustular psoriasis. Journal of the European Academy of Dermatology and Venereology. 39(3). 487–497. 4 indexed citations
4.
Mansour, Mark, Khalad Maliyar, Muskaan Sachdeva, et al.. (2024). 53838 Real-world drug survival of risankizumab at a tertiary care psoriasis clinic in Toronto, Canada. Journal of the American Academy of Dermatology. 91(3). AB294–AB294.
5.
Martínez‐Cabriales, Sylvia Aidé, Danielle Marcoux, Carmen Liy‐Wong, et al.. (2023). Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate‐to‐severe atopic dermatitis treated with dupilumab. Pediatric Dermatology. 41(1). 5–11. 6 indexed citations
6.
Adam, David N., Melinda Gooderham, Jennifer Beecker, et al.. (2023). Expert consensus on the systemic treatment of atopic dermatitis in special populations. Journal of the European Academy of Dermatology and Venereology. 37(6). 1135–1148. 42 indexed citations
7.
Maliyar, Khalad, et al.. (2023). Use of risankizumab in two HIV-positive patients with psoriasis. JAAD Case Reports. 33. 54–55. 5 indexed citations
8.
Yeung, Jensen, Melinda Gooderham, Charles Lynde, et al.. (2023). Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective. Journal of the American Academy of Dermatology. 89(2). 372–375. 11 indexed citations
9.
Piguet, Vincent, et al.. (2023). Brodalumab-Induced Eczematous Reactions in Psoriasis Patients: Management With Switching to Risankizumab. Journal of Cutaneous Medicine and Surgery. 27(3). 236–240. 2 indexed citations
10.
Zhao, Irene X., et al.. (2023). Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report. SHILAP Revista de lepidopterología. 11. 2050313X231180766–2050313X231180766. 1 indexed citations
11.
Le, Michelle, Feras M. Ghazawi, Marc Bourcier, et al.. (2021). Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis. Frontiers in Medicine. 8. 682547–682547. 22 indexed citations
12.
Yeung, Jensen, Ronald Vender, Irina Turchin, et al.. (2020). Brodalumab success in patients with moderate-to-severe psoriasis who failed previous interleukin-17A inhibitors. Journal of the American Academy of Dermatology. 84(4). 1169–1171. 14 indexed citations
13.
Lansang, Perla, Irene Lara‐Corrales, James N. Bergman, et al.. (2019). Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section IV: Consensus Statements on the Assessment and Management of Pediatric Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery. 23(5_suppl). 32S–39S. 12 indexed citations
14.
Lansang, Perla, James N. Bergman, Loretta Fiorillo, et al.. (2019). Management of pediatric plaque psoriasis using biologics. Journal of the American Academy of Dermatology. 82(1). 213–221. 28 indexed citations
15.
Fleming, Patrick, et al.. (2019). Undergraduate Dermatology Medical Education: Results of a Large-Scale Patient Viewing Program. Journal of Cutaneous Medicine and Surgery. 23(5). 482–487. 3 indexed citations
16.
Lara‐Corrales, Irene, James N. Bergman, Ian Landells, Michele Ramien, & Perla Lansang. (2019). Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section I: Overview of Pediatric Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery. 23(5_suppl). 3S–11S. 9 indexed citations
17.
Sade, Shachar, et al.. (2018). Eosinophils in the skin—a red herring masking lymphoma: a case series. SAGE Open Medical Case Reports. 6. 2050313X18773127–2050313X18773127. 1 indexed citations
18.
Gooderham, Melinda, Robert Bissonnette, Parbeer Grewal, et al.. (2018). Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section II: Tools for Assessing the Severity of Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery. 22(1_suppl). 10S–16S. 31 indexed citations
19.
Lee, Erika Yue, Raed Alhusayen, Perla Lansang, Neil H. Shear, & Jensen Yeung. (2017). What is hidradenitis suppurativa?. PubMed. 63(2). 114–120. 56 indexed citations
20.
Ho, Nhung, Perla Lansang, & Elena Pope. (2006). Topical imiquimod in the treatment of infantile hemangiomas: A retrospective study. Journal of the American Academy of Dermatology. 56(1). 63–68. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Igor Snast Breakdown of academic impact, for papers by Caleb Hwang Breakdown of academic impact, for papers by Jeffrey Zweegers Breakdown of academic impact, for papers by A. Villani Breakdown of academic impact, for papers by Alexander Marsland Breakdown of academic impact, for papers by S.P. Menting Breakdown of academic impact, for papers by María Jones‐Caballero Breakdown of academic impact, for papers by Sujoy Khan Breakdown of academic impact, for papers by Ravishankar Sargur Breakdown of academic impact, for papers by M. Fazio
Rankless by CCL
2026